NewMarket raises quarterly dividend by 10% to $2.75 per share
- Dividend Payment Date: NewMarket will pay a dividend on April 1, 2025.
- Record Date for Shareholders: Shareholders must be on record by the close of business on March 17, 2025, to receive the dividend.
Trade with 70% Backtested Accuracy
Analyst Views on NEU
About NEU
About the author
Neuren Pharmaceuticals' DAYBUE Expected to Reach $700 Million in Global Sales by 2028
- Sales Forecast: Neuren Pharmaceuticals anticipates that its prescription drug DAYBUE for Rett syndrome will achieve global net sales of $700 million by 2028, reflecting strong growth potential in the market.
- Patient Treatment: Since its U.S. launch, over 2,000 Rett patients have been treated with DAYBUE, with a 12-month treatment persistency increase of 55%, indicating high patient reliance and satisfaction with the drug.
- Market Expansion: The company continued to expand its U.S. customer-facing teams in the second quarter of 2025, further driving DAYBUE sales growth, which underscores its strategic focus on market penetration and customer service.
- New Product Launch: The DAYBUE STIX formulation is set to launch in the U.S. in the first quarter of 2026, with a full commercial rollout planned for the second quarter, marking a significant enhancement of the company's product line and competitive positioning.
NewMarket Corp Shares Drop to $695.94, Oversold Signal Emerges
- Oversold Condition: NewMarket Corp's stock price fell to $695.94 on Tuesday, with an RSI reading of 29.7 indicating an oversold condition, suggesting potential buying opportunities for investors.
- Dividend Yield: Based on the current price of $704.44, NEU's annualized dividend of $12 per share translates to a yield of 1.70%, making it an attractive option for dividend investors seeking higher returns.
- Market Comparison: NEU's low RSI compared to the average RSI of 52.0 for covered dividend stocks suggests that recent heavy selling may be exhausting, drawing interest from bullish investors.
- Investor Strategy: While dividends are not always predictable, analyzing NEU's dividend history can assist investors in assessing the likelihood of continued payments, enabling more informed investment decisions.
NewMarket (NYSE:NEU) Investors Achieve 36% Annual Growth Rate Over Past Three Years
Stock Performance: NewMarket Corporation's share price has increased by 137% over the last three years, with a recent 2.8% rise, indicating strong market sentiment aligned with its earnings per share (EPS) growth of 33% annually.
Total Shareholder Return: The total shareholder return (TSR) for NewMarket over the past three years is 151%, surpassing its share price return, largely due to dividends that have enhanced overall returns.
Recent Growth: NewMarket has delivered a 46% TSR in the last twelve months, suggesting improved business momentum compared to a 17% annualized return over the past five years.
Investment Considerations: While NewMarket shows promising returns, potential investors should be aware of one warning sign and consider insider buying trends before making investment decisions.
NewMarket Emphasizes Margin Strategy and Increases Dividend by 9% Following Calca Acquisition in Specialty Segment Expansion
Financial Performance: NewMarket Corporation reported a net income of $100 million for Q3 2025, down from $132 million in Q3 2024, with petroleum additives sales at $649 million and operating profit at $131 million, impacted by one-time charges and a 4.1% shipment decrease.
Strategic Investments: The company expanded its Specialty Materials segment by acquiring Calca Solutions, LLC, and plans to continue investing in technology and inventory optimization to enhance long-term value for shareholders.
Dividend Increase: NewMarket returned $155 million to shareholders in the first nine months of 2025, including a 9% increase in the quarterly dividend to $3 per share, effective January 2, 2026.
Market Challenges: Management acknowledged ongoing inflationary pressures and market softness affecting shipments, particularly in petroleum additives, while expressing confidence in cash flow and capital returns despite these challenges.
NewMarket Corporation Plans Conference Call and Webcast to Discuss Third Quarter 2025 Financial Results
Earnings Announcement: NewMarket Corporation plans to release its third quarter 2025 earnings on October 30, 2025, with a conference call scheduled for October 31, 2025, at 3:00 pm ET to discuss the results.
Company Overview: NewMarket operates through subsidiaries that produce chemical additives for petroleum products, specialty materials for aerospace and defense, and high-purity hydrazine for advanced applications, emphasizing a commitment to safety and innovation.
NewMarket Corporation Finalizes Purchase of Calca Solutions, LLC
Acquisition Announcement: NewMarket Corporation has completed the acquisition of Mars TopCo, LLC, the parent company of Calca Solutions, LLC, a leading producer of high-purity hydrazine, essential for aerospace and defense applications.
Strategic Growth: This acquisition, along with previous investments, is part of NewMarket's strategy to diversify and strengthen its presence in high-technology sectors, with a commitment of approximately $1 billion towards these efforts.
Neuren Pharmaceuticals' DAYBUE Expected to Reach $700 Million in Global Sales by 2028
- Sales Forecast: Neuren Pharmaceuticals anticipates that its prescription drug DAYBUE for Rett syndrome will achieve global net sales of $700 million by 2028, reflecting strong growth potential in the market.
- Patient Treatment: Since its U.S. launch, over 2,000 Rett patients have been treated with DAYBUE, with a 12-month treatment persistency increase of 55%, indicating high patient reliance and satisfaction with the drug.
- Market Expansion: The company continued to expand its U.S. customer-facing teams in the second quarter of 2025, further driving DAYBUE sales growth, which underscores its strategic focus on market penetration and customer service.
- New Product Launch: The DAYBUE STIX formulation is set to launch in the U.S. in the first quarter of 2026, with a full commercial rollout planned for the second quarter, marking a significant enhancement of the company's product line and competitive positioning.
NewMarket Corp Shares Drop to $695.94, Oversold Signal Emerges
- Oversold Condition: NewMarket Corp's stock price fell to $695.94 on Tuesday, with an RSI reading of 29.7 indicating an oversold condition, suggesting potential buying opportunities for investors.
- Dividend Yield: Based on the current price of $704.44, NEU's annualized dividend of $12 per share translates to a yield of 1.70%, making it an attractive option for dividend investors seeking higher returns.
- Market Comparison: NEU's low RSI compared to the average RSI of 52.0 for covered dividend stocks suggests that recent heavy selling may be exhausting, drawing interest from bullish investors.
- Investor Strategy: While dividends are not always predictable, analyzing NEU's dividend history can assist investors in assessing the likelihood of continued payments, enabling more informed investment decisions.
NewMarket (NYSE:NEU) Investors Achieve 36% Annual Growth Rate Over Past Three Years
Stock Performance: NewMarket Corporation's share price has increased by 137% over the last three years, with a recent 2.8% rise, indicating strong market sentiment aligned with its earnings per share (EPS) growth of 33% annually.
Total Shareholder Return: The total shareholder return (TSR) for NewMarket over the past three years is 151%, surpassing its share price return, largely due to dividends that have enhanced overall returns.
Recent Growth: NewMarket has delivered a 46% TSR in the last twelve months, suggesting improved business momentum compared to a 17% annualized return over the past five years.
Investment Considerations: While NewMarket shows promising returns, potential investors should be aware of one warning sign and consider insider buying trends before making investment decisions.
NewMarket Emphasizes Margin Strategy and Increases Dividend by 9% Following Calca Acquisition in Specialty Segment Expansion
Financial Performance: NewMarket Corporation reported a net income of $100 million for Q3 2025, down from $132 million in Q3 2024, with petroleum additives sales at $649 million and operating profit at $131 million, impacted by one-time charges and a 4.1% shipment decrease.
Strategic Investments: The company expanded its Specialty Materials segment by acquiring Calca Solutions, LLC, and plans to continue investing in technology and inventory optimization to enhance long-term value for shareholders.
Dividend Increase: NewMarket returned $155 million to shareholders in the first nine months of 2025, including a 9% increase in the quarterly dividend to $3 per share, effective January 2, 2026.
Market Challenges: Management acknowledged ongoing inflationary pressures and market softness affecting shipments, particularly in petroleum additives, while expressing confidence in cash flow and capital returns despite these challenges.
NewMarket Corporation Plans Conference Call and Webcast to Discuss Third Quarter 2025 Financial Results
Earnings Announcement: NewMarket Corporation plans to release its third quarter 2025 earnings on October 30, 2025, with a conference call scheduled for October 31, 2025, at 3:00 pm ET to discuss the results.
Company Overview: NewMarket operates through subsidiaries that produce chemical additives for petroleum products, specialty materials for aerospace and defense, and high-purity hydrazine for advanced applications, emphasizing a commitment to safety and innovation.
NewMarket Corporation Finalizes Purchase of Calca Solutions, LLC
Acquisition Announcement: NewMarket Corporation has completed the acquisition of Mars TopCo, LLC, the parent company of Calca Solutions, LLC, a leading producer of high-purity hydrazine, essential for aerospace and defense applications.
Strategic Growth: This acquisition, along with previous investments, is part of NewMarket's strategy to diversify and strengthen its presence in high-technology sectors, with a commitment of approximately $1 billion towards these efforts.
